"Executive Summary Middle East and Africa Pharmacogenetics Testing in Psychiatry/Depression Market : CAGR Value Data Bridge Market Research analyzes that the Middle East & Africa pharmacogenetics testing in psychiatry/depression market is expected to reach the value of USD 49.64 million by 2029, at a CAGR of 7.1% during the forecast period. The Middle East and Africa...